Pharma Equity Group A/S Stock

Pharma Equity Group A/S PEG

The PEG Ratio (Price/Earnings-to-Growth) of Pharma Equity Group A/S (PEG.CO) as of Aug 16, 2026 is -0.30.

PEG

-0.30

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Pharma Equity Group A/S is 2026 -0.30 . PEG Ratio (Price/Earnings-to-Growth) of Pharma Equity Group A/S was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

PEG Ratio (Price/Earnings-to-Growth) of Pharma Equity Group A/S is -0.30 in 2026.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Pharma Equity Group A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Pharma Equity Group A/S

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Pharma Equity Group A/S